Immunopharmacological profile of HWA 486, a novel isoxazol derivative— II. In vivo immunomodulating effects differ from those of cyclophosphamide, prednisolone, or cyclosporin A
- 1 January 1986
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 8 (2) , 199-204
- https://doi.org/10.1016/0192-0561(86)90059-7
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Immunopharmacological profile of a novel isoxazol derivative, HWA 486, with potential antirheumatic activity — I. Disease modifying action on adjuvant arthritis of the ratInternational Journal of Immunopharmacology, 1985
- Cyclosporine: Immunology, toxicity and pharmacology in experimental animalsInflammation Research, 1984
- Inhibition of the antigen activated T cell response by methylprednisolone is caused by inhibition of interleukin-2 (IL-2) productionInternational Journal of Immunopharmacology, 1984
- The effects of cyclosporins on the cell cycle of T-lymphoid cell linesExperimental Cell Research, 1982
- Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2European Journal of Immunology, 1981
- Effects of Methylprednisolone on the in Vitro Induction and Function of Suppressor Cells in ManScandinavian Journal of Immunology, 1980
- Concanavalin A-induced suppressor cell activity opposing effects of hydrocortisone.The Journal of Immunology, 1980
- SUPPRESSION OF HUMAN CYTOTOXIC LYMPHOCYTES BY METHYLPREDNISOLONETransplantation, 1978
- Biological effects of cyclosporin A: A new antilymphocytic agentInflammation Research, 1976
- Studies of Arthritis and Other Lesions Induced in Rats by Injection of Mycobacterial AdjuvantThe Journal of Immunology, 1960